Yoshikatsu Kanai Selected Research

3,4,5,3',4'-pentachlorobiphenyl

2/2006	Prenatal 3,3',4,4',5-pentachlorobiphenyl exposure modulates induction of rat hepatic CYP 1A1, 1B1, and AhR by 7,12-dimethylbenz[a]anthracene.
8/2005	CYP1 and AhR expression in 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of rats prenatally exposed to 3,3',4,4',5-pentachlorobiphenyl.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshikatsu Kanai Research Topics

Disease

101	Neoplasms (Cancer) 05/2024 - 03/2002
9	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2009
9	Glioma (Gliomas) 04/2020 - 03/2002
9	Gout 04/2016 - 09/2003
8	Carcinoma (Carcinomatosis) 01/2024 - 09/2002
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2011 - 04/2009
6	Squamous Cell Carcinoma of Head and Neck 11/2015 - 05/2004
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2009 - 09/2003
5	Adenocarcinoma 05/2024 - 10/2009
5	Neoplasm Metastasis (Metastasis) 09/2023 - 04/2010
5	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2023 - 10/2013
5	Mouth Neoplasms (Oral Cancer) 01/2014 - 03/2004
4	Inflammation (Inflammations) 01/2020 - 03/2016
4	Obesity 10/2018 - 06/2015
4	Renal hypouricemia 01/2014 - 09/2003
3	Carcinogenesis 01/2023 - 09/2003
3	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2012
3	Lymphatic Metastasis 01/2018 - 09/2010
3	Osteosarcoma (Osteogenic Sarcoma) 11/2017 - 05/2006
3	Starvation 01/2017 - 03/2007
3	Hepatocellular Carcinoma (Hepatoma) 11/2016 - 07/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2016 - 09/2003
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2013 - 10/2003
3	Colonic Neoplasms (Colon Cancer) 01/2010 - 01/2006
2	Disease Progression 04/2024 - 03/2024
2	Cholangiocarcinoma 04/2024 - 10/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2013
2	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 05/2019
2	Melanoma (Melanoma, Malignant) 01/2023 - 10/2015
2	Multiple Myeloma 01/2022 - 11/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2019 - 01/2015
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 04/2014
2	Infections 11/2016 - 05/2014
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 04/2016 - 02/2013
2	Adenocarcinoma of Lung 01/2015 - 01/2011
2	Acute Kidney Injury (Acute Renal Failure) 01/2014 - 12/2008
2	Hypoxia (Hypoxemia) 12/2011 - 01/2011
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2009 - 12/2008
2	Hyperuricemia 04/2008 - 09/2003
2	Blue diaper syndrome 04/2005 - 01/2002
2	Stroke (Strokes) 02/2004 - 10/2003

Drug/Important Bio-Agent (IBA)

97	Amino Acid Transport Systems (Amino Acid Transporter)IBA 05/2024 - 03/2002
24	Amino Acids FDA Link 03/2024 - 04/2005
15	Large Neutral Amino Acid-Transporter 1IBA 03/2024 - 09/2007
14	Neutral Amino AcidsIBA 03/2024 - 03/2004
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 12/2008
12	Essential Amino AcidsIBA 04/2024 - 03/2004
12	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2007
11	2- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA 04/2024 - 01/2010
11	Uric Acid (Urate)IBA 04/2016 - 09/2003
9	Leucine (L-Leucine)FDA Link 04/2024 - 09/2002
9	AcidsIBA 04/2020 - 08/2006
7	Tyrosine (L-Tyrosine)FDA Link 03/2021 - 11/2010
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
6	Glutamic Acid (Glutamate)FDA Link 01/2017 - 10/2003
6	Indicators and Reagents (Reagents)IBA 11/2015 - 05/2004
6	Heavy Chain Fusion Regulatory Protein 1IBA 09/2010 - 05/2004
5	TOR Serine-Threonine KinasesIBA 04/2024 - 01/2011
5	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 04/2013
4	urate transporterIBA 04/2016 - 09/2003
4	Protein Isoforms (Isoforms)IBA 03/2016 - 08/2012
4	Biomarkers (Surrogate Marker)IBA 12/2014 - 01/2009
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2014 - 12/2008
4	Amino Acid Transport System LIBA 04/2009 - 09/2002
3	Messenger RNA (mRNA)IBA 04/2024 - 03/2007
3	AndrogensIBA 12/2022 - 04/2013
3	Androgen Receptors (Androgen Receptor)IBA 12/2022 - 05/2016
3	Hormones (Hormone)IBA 12/2022 - 05/2016
3	Surface Antigens (Surface Antigen)IBA 01/2022 - 01/2019
3	Phenylalanine (L-Phenylalanine)FDA Link 12/2020 - 03/2019
3	Deoxyglucose (2 Deoxy D glucose)IBA 10/2013 - 11/2007
3	ErbB Receptors (EGF Receptor)IBA 12/2011 - 01/2011
3	AntigensIBA 08/2006 - 03/2002
2	Gemcitabine FDA Link 06/2023 - 10/2013
2	Neutral Amino Acid Transport SystemsIBA 01/2023 - 10/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2009
2	ProteomeIBA 01/2022 - 02/2021
2	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2022 - 01/2002
2	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 02/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2007
2	Organic Anion TransportersIBA 12/2020 - 04/2008
2	TurpentineIBA 01/2020 - 02/2017
2	CationsIBA 12/2017 - 12/2009
2	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 04/2009
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2017 - 04/2009
2	Sirolimus (Rapamycin)FDA Link 01/2017 - 12/2011
2	sodium-bile acid cotransporterIBA 11/2016 - 05/2014
2	Small Interfering RNA (siRNA)IBA 03/2016 - 07/2006
2	PlatinumIBA 04/2014 - 11/2011
2	Branched-Chain Amino AcidsIBA 04/2013 - 03/2007
2	TensinsIBA 12/2011 - 01/2011
2	HexokinaseIBA 12/2011 - 01/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2011 - 01/2011
2	SodiumIBA 06/2010 - 03/2002
2	3,4,5,3',4'-pentachlorobiphenylIBA 02/2006 - 08/2005
2	anthraceneIBA 08/2005 - 09/2003

Therapy/Procedure

30	Therapeutics 05/2024 - 03/2004
6	Drug Therapy (Chemotherapy) 06/2023 - 04/2007
4	Castration 04/2024 - 01/2021
2	Boron Neutron Capture Therapy 01/2022 - 03/2019